Berlin, Germany
Nia Health is carving a niche in the field of personalized medicine with a strong focus on addressing chronic skin conditions. Founded in 2019, the company has quickly gained recognition for its innovative approach towards reducing the societal and personal challenges faced by individuals with these conditions.
The company's flagship product, the award-winning eczema app Nia, is a testament to its commitment to providing digital healthcare solutions. As a product of a digital medical device manufacturer, the app exemplifies advanced medical software tailored to the needs of its users.
Although little information is available about past financial rounds or investor interest, Nia Health's dedication to technological advancement in healthcare offers a compelling prospect for potential investors seeking to dive into the burgeoning health-tech space.
